Tue May 06 16:44:33 UTC 2025: ## Minnesota Woman’s Stage 4 Colon Cancer Vanishes After Experimental Gene Therapy
**Minneapolis, MN** – A Minnesota woman, Emma Dimery, has achieved a remarkable remission from Stage 4 colon cancer after participating in a groundbreaking clinical trial. Diagnosed in 2013 at the age of 23 with a softball- and golf ball-sized tumor, Dimery endured years of conventional treatments including chemotherapy, radiation, and immunotherapy, all without success.
Facing a grim prognosis, Dimery enrolled in a University of Minnesota clinical trial led by Dr. Emil Lou. The trial employed a novel CRISPR-based gene editing therapy, a cutting-edge approach targeting the interior of cancer cells to disable their immune system defenses. Unlike traditional immunotherapies that focus on the cell’s exterior, this experimental treatment aimed to remove the “shield” protecting cancer cells from the body’s immune response.
Two months after completing the trial in early 2023, Dimery received life-changing news: all signs of her nearly decade-long battle with cancer had disappeared. Doctors found no evidence of disease.
“It was amazing,” Dimery shared. “My whole adult life up to that point I was pretty much a cancer patient.”
Dr. Lou explained that the success highlights the potential of this new generation of immunotherapy. Dimery’s case represents a significant milestone for the treatment, offering hope to others facing similar challenges. Two years post-trial, Dimery reports she is thriving and her perspective on cancer has been fundamentally altered. The trial’s success underscores the potential of CRISPR gene editing in cancer treatment.
First Piper 